Home/Filings/4/0000899243-18-006964
4//SEC Filing

Sham Hing 4

Accession 0000899243-18-006964

CIK 0001629137other

Filed

Mar 8, 7:00 PM ET

Accepted

Mar 9, 5:30 PM ET

Size

7.1 KB

Accession

0000899243-18-006964

Insider Transaction Report

Form 4
Period: 2018-03-07
Sham Hing
See Remarks
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-03-0710,71410,715 total
    Exercise: $0.49Exp: 2024-09-09Common Stock (10,714 underlying)
  • Exercise/Conversion

    Common Stock

    2018-03-07$0.49/sh+10,714$5,25098,215 total
Footnotes (1)
  • [F1]25% of the shares subject to this option shall vest and become exercisable on July 28, 2015, and the remaining shares subject to this option shall vest and become exercisable in 12 equal quarterly installments thereafter.

Issuer

Global Blood Therapeutics, Inc.

CIK 0001629137

Entity typeother

Related Parties

1
  • filerCIK 0001650158

Filing Metadata

Form type
4
Filed
Mar 8, 7:00 PM ET
Accepted
Mar 9, 5:30 PM ET
Size
7.1 KB